AVANOS MEDICAL INC (AVNS) Stock Income Statement
NYSE:AVNS - New York Stock Exchange, Inc. - US05350V1061 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 689.20M | 687.80M | 673.30M | 820.00M | 744.60M | |||
| Cost Of Goods | 312.90M | 306.50M | 293.60M | 370.00M | 380.30M | |||
| Gross Profit | 376.30M | 381.30M | 379.70M | 450.00M | 364.30M | |||
| Operating Expenses | 325.60M | 336.60M | 372.20M | 374.00M | 347.60M | |||
| Research and Development | 24.60M | 26.20M | 27.20M | 30.60M | 32.30M | |||
| Selling, General, and Administrative Expenses | 306.70M | 314.30M | 331.70M | 339.90M | 300.30M | |||
| Operating Income | 50.70M | 44.70M | 7.50M | 76.00M | 16.70M | |||
| Interest Income/Expense | -5.20M | -7.10M | -12.10M | -7.70M | -3.10M | |||
| Non Recurring Items | N/A | -440.90M | -3.30M | -3.10M | -7.80M | |||
| Income Before Taxes | -395.10M | -403.30M | -7.90M | 65.20M | 5.80M | |||
| Income Tax | -14.90M | -17.00M | 2.00M | 14.70M | 600.00K | |||
| Net Income | -384.60M | -392.10M | -61.80M | 50.50M | 5.20M | |||
| EBITDA | 94.40M | 90.20M | 53.60M | 123.70M | 55.00M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -8.37 | -8.52 | -1.32 | 1.07 | 0.11 | |||
| Non GAAP EPS | 1.33 | 1.26 | 1.38 | 1.65 | 1.15 | |||
| Statistics | ||||||||
| Gross Profit Margin | 54.60% | 55.44% | 56.39% | 54.88% | 48.93% | |||
| Profit Margin | -55.80% | -57.01% | -9.18% | 6.16% | 0.70% | |||
| Operating Profit Margin | 7.36% | 6.50% | 1.11% | 9.27% | 2.24% | |||
All data in USD